Clinical Trials

Published on: August 14, 2017 at 10:00AM Conditions:   Breast Cancer;   NeutropeniaInterventions:   Drug: F-627;   Drug: NeulastaSponsor:   Generon (Shanghai) Corporation Ltd.Not yet recruiting...

Published on: August 14, 2017 at 10:00AM Conditions:   Breast Cancer;   NeutropeniaInterventions:   Drug: F-627;   Drug: NeulastaSponsor:   Generon (Shanghai) Corporation Ltd.Not yet recruiting...

Published on: August 15, 2017 at 10:00AM Condition:   Chemotherapy-induced Abnormal Thermal SensationIntervention:   Diagnostic Test: Genetic variants of TRPV1, TRPM2, TRPA1 and...

Published on: August 12, 2017 at 10:00AM Condition:   Small Cell Lung Cancer Extensive StageIntervention:   Drug: Pembrolizumab plus amurubicinSponsors:   Wakayama Medical University;   Merck Sharp & Dohme Corp.Not yet recruiting - verified...

Published on: August 15, 2017 at 10:00AM Condition:   Cervical CancerIntervention:   Other: Self-samplingSponsor:   Western Health and Social Care TrustEnrolling by invitation - verified August 2017...

Published on: August 15, 2017 at 10:00AM Condition:   Cervical CancerIntervention:   Other: Self-samplingSponsor:   Western Health and Social Care TrustEnrolling by invitation - verified August 2017...

Published on: August 15, 2017 at 10:00AM Condition:   Cervical CancerIntervention:   Other: Self-samplingSponsor:   Western Health and Social Care TrustEnrolling by invitation - verified August 2017...

Published on: August 15, 2017 at 10:00AM Condition:   Cervical CancerIntervention:   Other: Self-samplingSponsor:   Western Health and Social Care TrustEnrolling by invitation - verified August 2017...

Published on: August 15, 2017 at 10:00AM Condition:   Cervical CancerIntervention:   Other: Self-samplingSponsor:   Western Health and Social Care TrustEnrolling by invitation - verified August 2017...

Published on: August 11, 2017 at 10:00AM Condition:   Breast NeoplasmsIntervention:   Drug: H3B-6545Sponsor:   H3 Biomedicine Inc.Not yet recruiting - verified August 2017...

Published on: August 11, 2017 at 10:00AM Condition:   Colorectal Cancer MetastaticIntervention:   Drug: Based on sensitivity analysisSponsor:   Vejle HospitalNot yet recruiting - verified August 2017...

Published on: August 15, 2017 at 10:00AM Condition:   EpendymomaIntervention:   Sponsor:   National Cancer Institute (NCI)Recruiting - verified August 3, 2017 http://ift.tt/2uOOziU

Published on: August 15, 2017 at 10:00AM Condition:   EpendymomaIntervention:   Sponsor:   National Cancer Institute (NCI)Recruiting - verified August 3, 2017 http://ift.tt/2uOOziU

Published on: August 15, 2017 at 10:00AM Condition:   EpendymomaIntervention:   Sponsor:   National Cancer Institute (NCI)Recruiting - verified August 3, 2017 http://ift.tt/2uOOziU

Published on: August 15, 2017 at 10:00AM Condition:   EpendymomaIntervention:   Sponsor:   National Cancer Institute (NCI)Recruiting - verified August 3, 2017 http://ift.tt/2uOOziU

Published on: August 15, 2017 at 10:00AM Condition:   EpendymomaIntervention:   Sponsor:   National Cancer Institute (NCI)Recruiting - verified August 3, 2017 http://ift.tt/2uOOziU

Published on: August 14, 2017 at 10:00AM Condition:   Esophageal Squamous Cell CarcinomaInterventions:   Drug: Irinotecan;   Drug: ApatinibSponsors:   Peking University;   Beijing Cancer HospitalRecruiting - verified...

Published on: August 15, 2017 at 10:00AM Conditions:   Cancer;   Tumors;   Neoplasm;   MalignancyInterventions:   Drug: BMS-986226;   Biological: Nivolumab;...